Literature DB >> 2307560

Efficient recovery of clonogenic stem cells from solid tumors and occult metastatic deposits.

B E Miller1, C J Aslakson, F R Miller.   

Abstract

We describe the use of enzymes combined with brief, sequential mechanical disruptions in a Tekmar Stomacher blender for the recovery of clonogenic neoplastic cells from solid tumors, lungs, and livers. The method has yielded 3 X 10(8) to 5 X 10(8) total cells and 1.2 X 10(6) to 17 X 10(6) clonogenic cells per gram of tissue from three different mouse mammary tumor subpopulations growing in the subcutis. The clonogenic cell yields represent a 4- to 13-fold increase over our previous best method of tumor disaggregation. The increase in total cells recovered, while not as dramatic (up to 3-fold), was statistically significant for two of the three tumor lines. We were also able to efficiently recover 125I-iododeoxyuridine labelled neoplastic cells from lungs and livers after injecting the cells intravenously. Over half of the total radiolabel present in these organs prior to disaggregation could be recovered in the cell suspensions obtained.

Entities:  

Mesh:

Year:  1990        PMID: 2307560

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  5 in total

1.  Inhibition of lung colonization at two different steps in the metastatic sequence.

Authors:  C J Aslakson; D McEachern; D H Conaway; F R Miller
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

Review 2.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

3.  Use of tumor lines with selectable markers in assessing the effect on experimental metastases of combination chemotherapy with alkylating agents.

Authors:  B E Miller; L Delmonico; K Vistisen; F R Miller
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

4.  Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia.

Authors:  J W Rak; D McEachern; F R Miller
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

5.  Melphalan sensitivity as a function of progressive metastatic growth in two subpopulations of a mouse mammary tumour.

Authors:  B E Miller; F R Miller; T Machemer; G H Heppner
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.